Isatuximab (for expansion) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: SAR-650984, Sarclisa, isatuximab-irfc

Filter by location:

Birmingham, Alabama1 trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

The University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.